Abstract
Two workflows are presented that are relevant to the design and construction of end-to-end pharmaceutical manufacturing processes. The workflows target the very early stage crystallisation aspect of these processes-production of the primary crystalline solid form-and relate to establishing decision-driven approaches for the screening for multi-component forms, specifically co-crystals, and to the use of additives to control crystal and primary particle form, notably morphology. These workflows are shown to benefit from the use of the million-plus structures in the Cambridge structural database and the associated structural informatics and analysis tools and are placed into the context of the work of the CMAC Future Manufacturing Hub.
Original language | English |
---|---|
Pages (from-to) | 7475-7489 |
Number of pages | 15 |
Journal | CrystEngComm |
Volume | 22 |
Issue number | 43 |
Early online date | 22 Sep 2020 |
DOIs | |
Publication status | Published - 21 Nov 2020 |
ASJC Scopus subject areas
- Chemistry(all)
- Materials Science(all)
- Condensed Matter Physics